Rachel Vaknin - 01 Apr 2022 Form 3 Insider Report for Microbot Medical Inc. (MBOT)

Role
Chief Financial Officer
Signature
/s/ Rachel Vaknin
Issuer symbol
MBOT
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
3
Filing time
15 Apr 2022, 17:00:56 UTC
Next filing
20 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MBOT Stock Option (Right to Buy) 01 Apr 2022 Common Stock, par value $0.001 per share 20,000 $6.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.